Rob Zenilman submits: Trailing 12 Month Price/Sales ratios of stocks covered in the Biotech sector ranged from 732.2 (ALXN) down to 2.4 (KOSP), with a median value of 8.4.
* View More Biotech Sector Charts *
Data in table version:
| | Closing Price | Sales per | Price / |
|---|
| Ticker | Company | 06/12/06 | Share-TTM | Sales-TTM |
|---|
| AFFX | Affymetrix Inc. | $26.80 | $5.42 |
4.9
| | ALXN | Alexion Pharmaceuticals Inc. | $32.70 | $0.04 |
732.2
| | AMGN | Amgen Inc. | $66.89 | $10.53 |
6.4
| | AMLN | Amylin Pharmaceuticals Inc. | $45.62 | $1.77 |
25.8
| | BIIB | Biogen Idec Inc. | $45.67 | $4.98 |
9.2
| | BMRN | BioMarin Pharmaceutical Inc. | $13.68 | $0.40 |
33.9
| | BSTE | Biosite Incorporated | $42.85 | $17.15 |
2.5
| | CELG | Celgene Corporation | $42.19 | $1.75 |
24.2
| | DNA | Genentech Inc. | $79.10 | $6.79 |
11.6
| | ELN | Elan Corp. plc | $15.48 | $1.21 |
12.7
| | GILD | Gilead Sciences Inc. | $56.16 | $5.03 |
11.2
| | GPRO | Gen-Probe Inc. | $47.85 | $6.27 |
7.6
| | IMCL | Imclone Systems Inc. | $40.32 | $6.46 |
6.2
| | INCY | Incyte Corp. | $4.04 | $0.14 |
29.7
| | ISTA | ISTA Pharmaceuticals Inc. | $6.40 | $0.60 |
10.6
| | KOSP | KOS Pharmaceuticals Inc. | $39.17 | $16.27 |
2.4
| | MEDI | MedImmune Inc. | $28.87 | $4.84 |
6.0
| | NABI | Nabi Biopharmaceuticals | $5.10 | $1.83 |
2.8
| | NBIX | Neurocrine Biosciences Inc. | $18.98 | $2.71 |
7.0
| | ONXX | Onyx Pharmaceuticals Inc. | $15.44 | $3.79 |
4.1
| | PGNX | Progenics Pharmaceuticals Inc. | $21.66 | $0.70 |
31.0
| | PHRM | Pharmion Corp. | $17.25 | $7.06 |
2.4
| | TELK | Telik Inc. | $15.69 | $3.00 |
5.2
| | VRTX | Vertex Pharmaceuticals Inc. | $30.41 | $1.56 |
19.5
|
Data: CapitalIQ
Related:
- Most recent opinion and analysis of Biotech stocks
-
Full transcripts of recent conference calls in the Biotech sector
-
Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a one-page recap of Jim Cramer's Mad Money TV show, Lightning Round, Radio program and Stop Trading?
